The OBF-1 gene locus confers B cell-specific transcription by restricting the ubiquitous activity of its promoter

European Journal of Immunology

Volumn 33, Issue 10, 2003, Pages 2864-2874

  Massa, Steffen ^a,c   Junker, Steffen ^b   Schubart, Karin ^a   Matthias, Gabriele ^a   Matthias, Patrick ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

B lymphocytes; Gene regulation; Transcription factors

Indexed keywords

CD40 ANTIGEN; IMMUNOGLOBULIN BINDING FACTOR; INTERLEUKIN 4; NEOMYCIN; OCT BINDING FACTOR 1; RNA POLYMERASE II; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR OBF 1; UNCLASSIFIED DRUG; DEOXYRIBONUCLEASE I; POU2AF1 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; ASSAY; B LYMPHOCYTE; BINDING SITE; BONE MARROW; CELL LINEAGE; CELL MATURATION; CELL SPECIFICITY; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; ENHANCER REGION; ENZYME SUBUNIT; GENE ACTIVITY; GENE CASSETTE; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE INDUCTION; GENE INSERTION; GENE LOCUS; GENE STRUCTURE; GENETIC CODE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GERMINAL CENTER; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; PROMOTER REGION; ANIMAL; CELL LINE; CHROMOSOME MAP; GENETICS; METABOLISM; MUTATION;

ANIMALS; B-LYMPHOCYTES; CELL LINE; CHROMOSOME MAPPING; DEOXYRIBONUCLEASE I; ENHANCER ELEMENTS (GENETICS); MICE; MUTATION; NEOMYCIN; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 0242271831     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200323882     Document Type: Article

References (30)

1. LaBella, F., Sive, H. L., Roeder, R. G. and Heintz, N., Cell-cycle regulation of a human histone H2b gene is mediated by the H2b subtype-specific consensus element. Genes Dev. 1988. 2: 32-39.
2. Hermanson, G. G., Briskin, M., Sigman, D. and Wall, R., Immunoglobulin enhancer and promoter motifs 5′ of the B29 B-cell-specific gene. Proc. Natl. Acad. Sci. USA 1989. 86: 7341-7345.
3. Christensen, S. M., Martin, B. K., Tan, S. S. and Weis, J. H., Identification of sites for distinct DNA binding proteins including Oct- 1 and Oct-2 in the Cr2 gene. J. Immunol. 1992. 148: 3610-3617.
4. Staudt, L. M. and Lenardo, M. J., Immunoglobulin gene transcription. Annu. Rev. Immunol. 1991. 9: 373-398.
5. Matthias, P., Lymphoid-specific transcription mediated by the conserved octamer site: who is doing what? Semin. Immunol. 1998. 10: 155-163.
6. Sturm, R. A., Das, G. and Herr, W., The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. Genes Dev. 1988. 2: 1582-1599.
7. Staudt, L. M., Singh, H., Sen, R., Wirth, T., Sharp, P. A. and Baltimore, D., A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature 1986. 323: 640-643.
8. Luo, Y., Fujii, H., Gerster, T. and Roeder, R. G., A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors. Cell 1992. 71: 231-241.
9. Corcoran, L. M., Karvelas, M., Nossal, G. J., Ye, Z. S., Jacks, T. and Baltimore, D., Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival. Genes Dev. 1993. 7: 570-582.
10. Gstaiger, M., Knoepfel, L., Georgiev, O., Schaffner, W. and Hovens, C. M., A B-cell coactivator of octamer-binding transcription factors. Nature 1995. 373: 360-362.
11. Luo, Y. and Roeder, R. G., Cloning, functional characterization, and mechanism of action of the B- cell-specific transcriptional coactivator OCA-B. Mol. Cell. Biol. 1995. 15: 4115-4124.
12. Strubin, M., Newell, J. W. and Matthias, P., OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer- binding proteins. Cell 1995. 80: 497-506.
13. Schubart, D. B., Rolink, A., Kosco-Vilbois, M. H., Botteri, F. and Matthias, P., B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation. Nature 1996. 383: 538-542.
14. Schubart, D. B., Rolink, A., Schubart, K. and Matthias, P., Cutting edge: lack of peripheral B cells and severe agammaglobulinemia in mice simultaneously lacking Bruton's tyrosine kinase and the B cell- specific transcriptional coactivator OBF-1. J. Immunol. 2000. 164: 18-22.
15. Qin, X. F., Reichlin, A., Luo, Y., Roeder, R. G. and Nussenzweig, M. C., OCA-B integrates B cell antigen receptor-, OD40L-and IL 4-mediated signals for the germinal center pathway of B cell development. EMBO J. 1998. 17: 5066-5075.
16. Pfisterer, P., Zwilling, S., Hess, J. and Wirth, T., Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1. J. Biol. Chem. 1995. 270: 29870-29880.
17. Schubart, D. B., Sauter, P., Massa, S., Friedl, E. M., Schwarzenbach, H. and Matthias, P., Gene structure and characterization of the murine homologue of the B cell-specific transcriptional coactivator OBF-1. Nucleic Acids Res. 1996. 24: 1913-1920.
18. Stevens, S., Wang, L. and Roeder, R. G., Functional analysis of the OCA-B promoter. J. Immunol. 2000. 164: 6372-6379.
19. Mansour, S. L., Thomas, K. R. and Capecchi, M. R., Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 1988. 336: 348-352.
20. Jones, K. A., Yamamoto, K. R. and Tjian, R., Two distinct transcription factors bind to the HSV thymidine kinase promoter in vitro. Cell 1985. 42: 559-572.
21. Zeh, K., Andahazy, M., O'Gorman, S. and Baribault, H., Selection of primary cell cultures with cre recombinase induced somatic mutations from transgenic mice. Nucleic Acids Res. 1998. 26: 4301-4303.
22. Massa, S., Junker, S. and Matthias, P., Molecular mechanisms of extinction: old findings and new ideas. Int. J. Biochem. Cell Biol. 2000. 32: 23-40.
23. Junker, S., Pedersen, S., Schreiber, E. and Matthias, P., Extinction of an immunoglobulin kappa promoter in cell hybrids is mediated by the octamer motif and correlates with suppression of Oct-2 expression. Cell 1990. 61: 467-474.
24. Junker, S., Lamm, M., Nielsen, V. and Matthias, P., Extinction of immunoglobulin gene expression in B cells upon fusion with HeLa cells is preceded by rapid nuclear depletion of essential transcription factors and is accompanied by widespread inactivation of genes expressed in a B cell-specific manner. J. Cell Sci. 1997. 110: 2579-2587.
25. Dorsey, M. J., Tae, H. J., Sollenberger, K. G., Mascarenhas, N. T, Johansen, L. M. and Taparowsky, E. J., B-ATF: a novel human bZIP protein that associates with members of the AP-1 transcription factor family. Oncogene 1995. 11: 2255-2265.
26. Hardison, R. C., Conserved noncoding sequences are reliable guides to regulatory elements. Trends Genet. 2000. 16: 369-372.
27. Makar, K. W., Pham, C. T, Dehoff, M. H., O'Connor, S. M., Jacobi, S. M. and Holers, V. M., An intronic silencer regulates B lymphocyte cell- and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene. J. Immunol. 1998. 160: 1268-1278.
28. Stewart, A. F., Reik, A. and Schutz, G., A simpler and better method to cleave chromatin with DNase 1 for hypersensitive site analyses. Nucleic Acids Res. 1991. 19: 3157.
29. Kit, Dubbs, D. R., Piekarski, L. J. and Hsu, T. C., Deletion of thymidine kinase activity from L-cells resistant to bromodeoxyuridine. Exp. Cell Res. 1963. 31: 297-312.
30. Junker, S., Nielsen, V., Matthias, P. and Picard, D., Both immunoglobulin promoter and enhancer sequences are targets for suppression in myeloma-fibroblast hybrid cells. EMBO J. 1988. 7: 3093-3098.